Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis

Hepatology

Volumn 61, Issue 5, 2015, Pages 1462-1464

  Torres, Dawn M ^a   Harrison, Stephen A ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CARBOHYDRATE DIET; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHRONIC LIVER DISEASE; CLINICAL PRACTICE; DIABETES MELLITUS; EPIDEMIC; EXERCISE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GENETIC PREDISPOSITION; GOLD STANDARD; HEALTH CARE COST; HEPATITIS C; HUMAN; LIFESTYLE MODIFICATION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOLOGIST; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEDENTARY LIFESTYLE; WEIGHT REDUCTION; FEMALE; MALE; MORTALITY; PATHOLOGY;

FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84928215996     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27680     Document Type: Article

References (11)

1. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-131.
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-1395.
3. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008;28:339-350.
4. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnosis accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011;54:1082-1090.
5. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
6. Younossi ZM, Stepanova M, Rafiq N, Makhlouf H, Younoszai Z, Agrawal R, et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver related mortality. Hepatology 2011;54:1874-1882.
7. Ekstedt M, Hagstrom H, Nasr, Fredrikson M, Stål P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015;61:1547-1554.
8. Sookoian S, Pirola CJ. Nonalcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008;49:600-607.
9. Hashimoto E, Tokushige K. Hepatocellular carcinoma is nonalcoholic steatohepatitis: growing evidence of an epidemic? Hepatol Res 2012;42:1-14.
10. Kawamura Y, Arase Y, Ikeda K, Seko Y, Imai N, Hosaka T, et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol 2012;107:253-261.
11. Farrell G. Insulin resistance, obesity and liver cancer. Clin Gastroenterol Hepatol 2014;12:117-119.